Prescription RequiredMOUNJARO KwikPen (Tirzepatide) 5 mg/0.6 mL is a prescription once-weekly injectable medicine used to improve blood sugar control in adults with type 2 diabetes. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist that helps regulate blood glucose levels, reduce appetite, and support weight management when used alongside a healthy diet and regular exercise. The 5 mg dose is commonly used after the initial 2.5 mg starting dose.
| Generic name | Tirzepatide |
| Strength | 5 mg |
| Manufacturer | Eli Lilly and Company |
| Package size | 1 pre-filled 2.4 ml pen |
| Used for | Type 2 diabetes and chronic weight management |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Tirzepatide 5 mg works by activating both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. It increases insulin release when blood sugar levels are high, reduces glucagon production, slows stomach emptying, and decreases appetite. These combined effects help improve blood sugar control and support weight management.
